Skip to main content
Erschienen in: European Surgery 5/2017

19.04.2017 | original article

Effects of teduglutide on histological parameters of intestinal anastomotic healing

verfasst von: Beatriz P. Costa, Maria A. Cipriano, Ana C. Gonçalves, Ana M. Abrantes, Paulo Matafome, Raquel Seiça, Ana B. Sarmento-Ribeiro, M. Filomena Botelho, Francisco Castro-Sousa

Erschienen in: European Surgery | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Summary

Background

Intestinal anastomotic failure continues to be one of the most relevant surgical incidents. Teduglutide is an enterotrophic long-acting equivalent of glucagon-like peptide-2 (GLP-2) recommended for the treatment of adult patients with short bowel syndrome. This study evaluates the effects of short-term teduglutide administration on histological parameters of intestinal anastomotic healing in an animal model.

Methods

Wistar rats (n = 31) were submitted to ileal resection and standard anastomosis, with or without postoperative teduglutide ministration, and sacrificed at the third or seventh day with tissue and blood sampling. Intestinal anastomotic healing was assessed with the modified Houdart–Hutschenreiter classification after hematoxylin and eosin staining. Collagen content and distribution were evaluated with the Gordon and Sweet technique; neoangiogenesis and epithelial proliferation indexes with anti-CD31 and anti-Ki67 immunostaining, respectively. GLP-2 plasma levels were determined by quantitative enzyme immunoassay.

Results

Teduglutide administration was associated with higher levels of reepithelialization (P = 0.022) and a higher neoangiogenesis index (neovessel density = 16.0 ± 10.8/mm2 vs. 5.3 ± 3.4/mm2; P = 0.0001) at the seventh postoperative day. Lower expression of type I collagen (P = 0.015) and higher content of type III collagen (P = 0.007) in the submucosa were also documented at the seventh day in teduglutide-treated animals. Drug administration was not associated with statistically significant differences of GLP-2 plasma levels.

Conclusion

These findings indicate a positive impact of teduglutide on the reepithelialization and neoangiogenesis events of the proliferative phase of intestinal anastomotic repair. Additional studies are necessary to clarify its effects on the fibrogenesis process.
Literatur
1.
2.
Zurück zum Zitat Thompson SK, Chang EY, Jobe BA. Clinical review: healing in gastrointestinal anastomoses, part I. Microsurgery. 2006;26(3):131–6.CrossRefPubMed Thompson SK, Chang EY, Jobe BA. Clinical review: healing in gastrointestinal anastomoses, part I. Microsurgery. 2006;26(3):131–6.CrossRefPubMed
3.
Zurück zum Zitat Rijcken E, Sachs L, Fuchs T, et al. Growth factors and gastrointestinal anastomotic healing. J Surg Res. 2014;187(1):202–10.CrossRefPubMed Rijcken E, Sachs L, Fuchs T, et al. Growth factors and gastrointestinal anastomotic healing. J Surg Res. 2014;187(1):202–10.CrossRefPubMed
4.
Zurück zum Zitat Øines MN, Krarup P, Jorgensen LN, et al. Pharmacological interventions for improved colonic anastomotic healing: a meta-analysis. World J Gastroenterol. 2014;20(35):12637–48.CrossRefPubMedPubMedCentral Øines MN, Krarup P, Jorgensen LN, et al. Pharmacological interventions for improved colonic anastomotic healing: a meta-analysis. World J Gastroenterol. 2014;20(35):12637–48.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Vakalopoulos KA, Daams F, Wu Z, et al. Tissue adhesives in gastrointestinal anastomosis: a systematic review. J Surg Res. 2013;180(2):290–300.CrossRefPubMed Vakalopoulos KA, Daams F, Wu Z, et al. Tissue adhesives in gastrointestinal anastomosis: a systematic review. J Surg Res. 2013;180(2):290–300.CrossRefPubMed
6.
Zurück zum Zitat Drucker DJ, Yusta B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol. 2014;76:561–83.CrossRefPubMed Drucker DJ, Yusta B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol. 2014;76:561–83.CrossRefPubMed
7.
Zurück zum Zitat Janssen P, Rotondo A, Mulé F, et al. Review article: a comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther. 2013;37(1):18–36.CrossRefPubMed Janssen P, Rotondo A, Mulé F, et al. Review article: a comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther. 2013;37(1):18–36.CrossRefPubMed
8.
Zurück zum Zitat Burness CB, McCormack PL. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome. Drugs. 2013;73(9):935–47.CrossRefPubMed Burness CB, McCormack PL. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome. Drugs. 2013;73(9):935–47.CrossRefPubMed
9.
Zurück zum Zitat Van Landeghem L, Blue RE, Dehmer JJ, et al. Localized intestinal radiation and liquid diet enhance survival and permit evaluation of long-term intestinal responses to high dose radiation in mice. PLOS ONE. 2012;7(12):e51310.CrossRefPubMedPubMedCentral Van Landeghem L, Blue RE, Dehmer JJ, et al. Localized intestinal radiation and liquid diet enhance survival and permit evaluation of long-term intestinal responses to high dose radiation in mice. PLOS ONE. 2012;7(12):e51310.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hulka JK, Omran K, Berger GS. Classification of adnexal adhesions: a proposal and evaluation of its prognostic value. Fertil Steril. 1978;30(6):661–5.CrossRefPubMed Hulka JK, Omran K, Berger GS. Classification of adnexal adhesions: a proposal and evaluation of its prognostic value. Fertil Steril. 1978;30(6):661–5.CrossRefPubMed
11.
Zurück zum Zitat Cakmak G, Irkorucu O, Ucan B, et al. Simvastatin improves wound strength after intestinal anastomosis in the rat. J Gastrointest Surg. 2009;13(9):1707–16.CrossRef Cakmak G, Irkorucu O, Ucan B, et al. Simvastatin improves wound strength after intestinal anastomosis in the rat. J Gastrointest Surg. 2009;13(9):1707–16.CrossRef
14.
Zurück zum Zitat Mall JW, Schwenk W, Philipp AW, et al. Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model. World J Surg. 2003;27(10):1119–23.CrossRefPubMed Mall JW, Schwenk W, Philipp AW, et al. Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model. World J Surg. 2003;27(10):1119–23.CrossRefPubMed
15.
Zurück zum Zitat Inglin RA, Baumann G, Wagner OJ, et al. Insulin-like growth factor I improves aspects of mycophenolatemofetil-impaired anastomotic healing in an experimental model. Br J Surg. 2008;95(6):793–8.CrossRefPubMed Inglin RA, Baumann G, Wagner OJ, et al. Insulin-like growth factor I improves aspects of mycophenolatemofetil-impaired anastomotic healing in an experimental model. Br J Surg. 2008;95(6):793–8.CrossRefPubMed
16.
Zurück zum Zitat Rekhtman N, Bishop JA. Quick reference handbook for surgical pathologists. Berlin Heidelberg: Springer; 2011.CrossRef Rekhtman N, Bishop JA. Quick reference handbook for surgical pathologists. Berlin Heidelberg: Springer; 2011.CrossRef
17.
Zurück zum Zitat Dubé PE, Brubaker PL. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab. 2007;293(2):E460–5.CrossRefPubMed Dubé PE, Brubaker PL. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab. 2007;293(2):E460–5.CrossRefPubMed
18.
Zurück zum Zitat Gelse K, Pöschl E, Aigner T. Collagens – structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531–46.CrossRefPubMed Gelse K, Pöschl E, Aigner T. Collagens – structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531–46.CrossRefPubMed
19.
Zurück zum Zitat Chen CZ, Raghunath M. Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis – state of the art. Fibrogenesis Tissue Repair. 2009;2:7.CrossRefPubMedPubMedCentral Chen CZ, Raghunath M. Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis – state of the art. Fibrogenesis Tissue Repair. 2009;2:7.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hendriks T, Maastboom WJ. Healing of experimental intestinal anastomoses. Parameters of repair. Dis Colon Rectum. 1990;33(10):891–901.CrossRefPubMed Hendriks T, Maastboom WJ. Healing of experimental intestinal anastomoses. Parameters of repair. Dis Colon Rectum. 1990;33(10):891–901.CrossRefPubMed
21.
Zurück zum Zitat Martin GR, Wallace LE, Hartmann B, et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G431–G438.CrossRefPubMed Martin GR, Wallace LE, Hartmann B, et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G431–G438.CrossRefPubMed
22.
Zurück zum Zitat Garrison AP, Dekaney CM, von Allmen DC, et al. Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion. Am J Physiol Gastrointest Liver Physiol. 2009;296(3):G643–G650.CrossRefPubMed Garrison AP, Dekaney CM, von Allmen DC, et al. Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion. Am J Physiol Gastrointest Liver Physiol. 2009;296(3):G643–G650.CrossRefPubMed
23.
Zurück zum Zitat Koopmann MC, Liu X, Boehler CJ, et al. Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome. JPEN J Parenter Enteral Nutr. 2009;33(6):629–39.CrossRefPubMedPubMedCentral Koopmann MC, Liu X, Boehler CJ, et al. Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome. JPEN J Parenter Enteral Nutr. 2009;33(6):629–39.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Muto M, Kaji T, Mukai M, et al. Ghrelin and glucagon-like peptide-2 increase immediately following massive small bowel resection. Peptides. 2013;43:160–6.CrossRefPubMed Muto M, Kaji T, Mukai M, et al. Ghrelin and glucagon-like peptide-2 increase immediately following massive small bowel resection. Peptides. 2013;43:160–6.CrossRefPubMed
25.
Zurück zum Zitat Tappenden KA. Intestinal adaptation following resection. JPEN J Parenter Enteral Nutr. 2014;38(1 Suppl):23S–31S.CrossRefPubMed Tappenden KA. Intestinal adaptation following resection. JPEN J Parenter Enteral Nutr. 2014;38(1 Suppl):23S–31S.CrossRefPubMed
26.
Zurück zum Zitat Pommergaard HC. Experimental evaluation of clinical colon anastomotic leakage. Dan Med J. 2014;61(3):B4821.PubMed Pommergaard HC. Experimental evaluation of clinical colon anastomotic leakage. Dan Med J. 2014;61(3):B4821.PubMed
27.
Zurück zum Zitat Pommergaard HC, Rosenberg J, Schumacher-Petersen C, et al. Choosing the best animal species to mimic clinical colon anastomotic leakage in humans: a qualitative systematic review. Eur Surg Res. 2011;47(3):173–81.CrossRefPubMed Pommergaard HC, Rosenberg J, Schumacher-Petersen C, et al. Choosing the best animal species to mimic clinical colon anastomotic leakage in humans: a qualitative systematic review. Eur Surg Res. 2011;47(3):173–81.CrossRefPubMed
28.
Zurück zum Zitat Mantzoros I, Kanellos I, Angelopoulos S, et al. The effect of insulin-like growth factor I on healing of colonic anastomoses in cortisone-treated rats. Dis Colon Rectum. 2006;49(9):1431–8.CrossRefPubMed Mantzoros I, Kanellos I, Angelopoulos S, et al. The effect of insulin-like growth factor I on healing of colonic anastomoses in cortisone-treated rats. Dis Colon Rectum. 2006;49(9):1431–8.CrossRefPubMed
29.
Zurück zum Zitat Zacharakis E, Demetriades H, Pramateftakis MG, et al. Effect of IGF-I on healing of colonic anastomoses in rats under 5‑FU treatment. J Surg Res. 2008;144(1):138–44.CrossRefPubMed Zacharakis E, Demetriades H, Pramateftakis MG, et al. Effect of IGF-I on healing of colonic anastomoses in rats under 5‑FU treatment. J Surg Res. 2008;144(1):138–44.CrossRefPubMed
30.
Zurück zum Zitat Rijcken E, Fuchs T, Sachs L, et al. Insulin-like growth factor 1‑coated sutures improve anastomotic healing in an experimental model of colitis. Br J Surg. 2010;97(2):258–65.CrossRefPubMed Rijcken E, Fuchs T, Sachs L, et al. Insulin-like growth factor 1‑coated sutures improve anastomotic healing in an experimental model of colitis. Br J Surg. 2010;97(2):258–65.CrossRefPubMed
31.
Zurück zum Zitat Radulescu A, Zhang HY, Chen CL, et al. Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing. J Surg Res. 2011;171(2):540–50.CrossRefPubMed Radulescu A, Zhang HY, Chen CL, et al. Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing. J Surg Res. 2011;171(2):540–50.CrossRefPubMed
32.
Zurück zum Zitat Egger B, Inglin R, Zeeh J, et al. Insulin-like growth factor I and truncated keratinocyte growth factor accelerate healing of left-sided colonic anastomoses. Br J Surg. 2001;88(1):90–8.CrossRefPubMed Egger B, Inglin R, Zeeh J, et al. Insulin-like growth factor I and truncated keratinocyte growth factor accelerate healing of left-sided colonic anastomoses. Br J Surg. 2001;88(1):90–8.CrossRefPubMed
33.
Zurück zum Zitat Baldassano S, Amato A, Cappello F, et al. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. J Endocrinol. 2013;217(1):11–20.CrossRefPubMed Baldassano S, Amato A, Cappello F, et al. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. J Endocrinol. 2013;217(1):11–20.CrossRefPubMed
34.
Zurück zum Zitat El-Jamal N, Erdual E, Neunlist M, et al. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307(3):G274–G285.CrossRefPubMed El-Jamal N, Erdual E, Neunlist M, et al. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307(3):G274–G285.CrossRefPubMed
35.
Zurück zum Zitat Martin GR, Wallace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2004;286(6):G964–G972.CrossRefPubMed Martin GR, Wallace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2004;286(6):G964–G972.CrossRefPubMed
36.
Zurück zum Zitat Kaji T, Tanaka H, Holst JJ, et al. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat. Eur J Pharmacol. 2008;596(1-3):138–45.CrossRefPubMed Kaji T, Tanaka H, Holst JJ, et al. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat. Eur J Pharmacol. 2008;596(1-3):138–45.CrossRefPubMed
37.
Zurück zum Zitat Kaji T, Tanaka H, Redstone H, et al. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection. J Surg Res. 2009;152(2):271–80.CrossRefPubMed Kaji T, Tanaka H, Redstone H, et al. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection. J Surg Res. 2009;152(2):271–80.CrossRefPubMed
38.
Zurück zum Zitat Arda-Pirincci P, Oztay F, Bayrak BB, et al. Teduglutide, a glucagon-like peptide 2 analogue: a novel protective agent with anti-apoptotic and anti-oxidant properties in mice with lung injury. Peptides. 2012;38(2):238–47.CrossRefPubMed Arda-Pirincci P, Oztay F, Bayrak BB, et al. Teduglutide, a glucagon-like peptide 2 analogue: a novel protective agent with anti-apoptotic and anti-oxidant properties in mice with lung injury. Peptides. 2012;38(2):238–47.CrossRefPubMed
39.
Zurück zum Zitat Alters SE, McLaughlin B, Spink B, et al. GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn’s disease model. PLOS ONE. 2012;7(11):e50630.CrossRefPubMedPubMedCentral Alters SE, McLaughlin B, Spink B, et al. GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn’s disease model. PLOS ONE. 2012;7(11):e50630.CrossRefPubMedPubMedCentral
Metadaten
Titel
Effects of teduglutide on histological parameters of intestinal anastomotic healing
verfasst von
Beatriz P. Costa
Maria A. Cipriano
Ana C. Gonçalves
Ana M. Abrantes
Paulo Matafome
Raquel Seiça
Ana B. Sarmento-Ribeiro
M. Filomena Botelho
Francisco Castro-Sousa
Publikationsdatum
19.04.2017
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 5/2017
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-017-0478-9

Weitere Artikel der Ausgabe 5/2017

European Surgery 5/2017 Zur Ausgabe